RGNT — REGENTIS BIOMATERIALS LTD.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1912966 ·
Israel
Last close
$1.89
Market Cap
$13.28M
52W High
$15.50
52W Low
$1.23
ADV30
51,567
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 7,618,000 | 7,378,000 | 2,874,000 |
| Jun 2025 | — | — | — | — | 475,000 | 189,000 | 44,807,000 |
| Dec 2024 | — | — | — | — | 482,000 | 229,000 | 41,586,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-55,794,000
Inventory
—
Receivables
$230,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -8,619,000 | -13,648,000 | 7,618,000 | 2,874,000 | 4,744,000 | -1,375,000 |
| Dec 2024 | 0 | 932,000 | 4,801,000 | 482,000 | 41,586,000 | -41,104,000 | -641,000 |
| Dec 2023 | 0 | -1,931,000 | -4,132,000 | 360,000 | 46,265,000 | -45,905,000 | -1,220,000 |
| Dec 2022 | 0 | -1,407,000 | -1,449,000 | 1,717,000 | 43,778,000 | -42,061,000 | -1,504,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SINT | Sintx Technologies, Inc. | $13.26M | $1.99 | — |
| CTSO | Cytosorbents Corp | $12.67M | $4.02 | — |
| PLSM | Pulsenmore Ltd. | $14.80M | $2.28 | — |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $11.84M | $1.30 | — |
| ICU | SeaStar Medical Holding Corp | $14.98M | $3.40 | — |
News headlines (Yahoo Finance, 1h cache)
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.
2026-09-18 14:15 · Yahoo
Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
2026-09-14 19:26 · Yahoo
Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks
2026-08-17 18:16 · Yahoo
Regentis Biomaterials (RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market
2026-08-14 18:30 · Yahoo
Regentis Biomaterials (RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair
2026-08-03 19:30 · Yahoo
Regentis Biomaterials (RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair Market
2026-07-27 19:00 · Yahoo
Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
2026-07-20 13:00 · Yahoo
Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process
2026-07-16 15:30 · Yahoo
Why Did RGNT Stock Surge More Than 850% Today?
2026-06-15 18:06 · Yahoo
Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC
2026-06-08 19:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.